Milk fat phospholipids reduce stress, says trial
Image: Fonterra
Dr. Maher Fuad, a research clinician at the Fonterra Research and Development Centre (FRDC), is preparing to unveil ground breaking discoveries regarding the impact of Nutiani Phospholipids [sourced from milk fat globule membrane (MFGM)] supplementation on psychological well-being. He will be speaking at the ISSFAL Conference in Nantes, France.
In collaboration with teams from The University of Auckland and the University of Otago, Dr. Fuad ran a 12-week clinical trial aimed at investigating the effects of phospholipid supplementation via MFGM source on mental well-being in healthy adults facing moderate stress. Preliminary findings from the trial are highly encouraging. Participants who received Nutiani Phospholipids supplementation experienced significant reductions in stress levels compared to those in the placebo group. Furthermore, there are promising indications that phospholipid supplementation may lead to anxiety reduction after 12 weeks.
Unlike single phospholipid sources, Nutiani Phospholipids are broad-spectrum phospholipids, containing a range of major phospholipids and sphingolipids – including phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and sphingomyelin. Each of these is present in a similar concentration to that of the human brain.
These findings carry significant implications for the field of mental health, as millions of individuals worldwide grapple with psychological challenges. Dr. Fuad’s presentation at the ISSFAL Congress will provide further insights into the potential of broad-spectrum phospholipids sourced from MFGM to enhance psychological well-being, instilling hope for effective interventions.
The ISSFAL Congress is a prestigious international gathering that brings together prominent researchers, clinicians, and nutritionists to discuss advancements in fatty acids and lipids.
